Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Non-langerhans cell histiocytosis"
Filter
Filter
Article category
Keywords
Publication year
Authors
Case Report
Case Report of Erdheim-Chester Disease Successfully Treated with Pegylated Interferon: A Single-Center Experience
Yujin Lim, Sang Eun Yoon, Junhun Cho, Darae Kim, Chul Won Jung
Cancer Res Treat. 2023;55(3):1053-1057.   Published online January 19, 2023
DOI: https://doi.org/10.4143/crt.2022.1535
AbstractAbstract PDFPubReaderePub
Erdheim-Chester disease (ECD), also known as non-Langerhans cell histiocytosis, is a multi-systemic disease with unclear pathogenesis. Based on a small number of case studies, pegylated interferon-α (PEG-IFN-α) has been used as the front-line treatment option. However, there are limited data regarding administration of ropegylated-interferon α-2b (ROPEG-IFN-α 2b) for ECD patients. Herein, we report two cases of severe ECD treated with two types of PEG-IFN-α. One patient with heart and skeleton involvement and BRAF V600E mutation was treated with weekly PEG-IFN-α 2a. Another patient with bone involvement and no BRAF V600E mutation was administered monthly ROPEG-IFN-α 2b. The two types of PEG-IFN-α showed excellent disease control, excellent survival outcomes, and manageable toxicities in ECD patients. These results suggest that ROPEG-IFN-α 2b could be used equivalently to PEG-IFN-α 2a for management of advanced ECD.

Citations

Citations to this article as recorded by  
  • An Autopsied Case of Erdheim-Chester Disease with Severe Cardiovascular Involvement
    Atsushi Matsunashi, Wang Zhipeng, Akihiko Sugimoto, Masakazu Fujimoto, Akihiko Yoshizawa, Ryo Sakamoto, Michihiro Uyama, Kohei Ikezoe, Kiminobu Tanizawa, Tomohiro Handa, Toyohiro Hirai
    Internal Medicine.2025;[Epub]     CrossRef
  • Recent advances in therapeutic strategies of Erdheim-Chester disease
    Rohit Doke, Rahul Lokhande, Kalyani Chande, Kuldeep Vinchurkar, Bhupendra G. Prajapati
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub]     CrossRef
  • Erdheim–Chester disease: Comprehensive insights from genetic mutations to clinical manifestations and therapeutic advances
    Rishabh Chaudhary, Anand Kumar, Alpana Singh, Vipul Agarwal, Mujeeba Rehman, Arjun Singh Kaushik, Siddhi Srivastava, Sukriti Srivastava, Vikas Mishra
    Disease-a-Month.2025; 71(2): 101845.     CrossRef
  • Advances in Understanding and Management of Erdheim-Chester Disease
    Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Jesil Mathew Aranjani
    Life Sciences.2024; 348: 122692.     CrossRef
  • 3,838 View
  • 166 Download
  • 4 Web of Science
  • 4 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP